Does zinc supplementation increase the risk of prostate cancer?

Archives of Ophthalmology

Volumn 123, Issue 1, 2005, Pages 102-103

  Jarrard, David F ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZINC;

ADULT; AFRICAN AMERICAN; AGED; CANCER GROWTH; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; DIET SUPPLEMENTATION; GERIATRICS; HEREDITY; HUMAN; INCIDENCE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RACE; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; SHORT SURVEY; SUPPLEMENTATION; UNITED STATES;

DIETARY SUPPLEMENTS; HUMANS; MALE; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; ZINC;

EID: 12144274030     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.123.1.102     Document Type: Short Survey

References (18)

1. Briefel RR, Bialostosky K, Kennedy-Stephenson J, McDowell MA, Ervin RB, Wright JD. Zinc intake of the US population: findings from the Third National Health and Mutrition Examination Survey, 1988-1994. J Nutr. 2000;130:1367S- 1373S.
2. Liang JY, Liu YY, Zou J, Franklin RB, Costello LC, Feng P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate. 1999;40:200-207.
3. Uzzo RG, Leavis P, Hatch W, et al. Zinc inhibits nuclear factor-kappa B activation and sensitizes prostate cancer cells to cytotoxic agents. Clin Cancer Res. 2002;8:3579-3583.
4. Brys M, Nawrocka AD, Miekos E, et al. Zinc and cadmium analysis in human prostate neoplasms. Biol Trace Elem Res. 1997;59:145-152.
5. Zaichick VY, Sviridova TV, Zaichick SV. Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol. 1997;29:565-574.
6. Henshall SM, Afar DE, Rasiah KK, et al. Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer. Oncogene. 2003;22:6005-6012.
7. Rishi I, Baidouri H, Abbasi JA, et al. Prostate cancer in African American men is associated with downregulation of zinc transporters. Appl Immunohistochem Mol Morphol. 2003;11:253-260.
8. Whelan P, Walker BE, Kelleher J. Zinc, vitamin A and prostatic cancer. Br J Urol. 1983;55:525-528.
9. Ogunlewe JO, Osegbe DN. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate. Cancer. 1989;63:1388-1392.
10. Feustel A, Wennrich R, Schmidt B. Serum-Zn-levels in prostatic cancer. Urol Res. 1989;17:41-42.
11. Habib FK, Dembinski TC, Stitch SR. The zinc and copper content of blood leucocytes and plasma from patients with benign and malignant prostates. Clin Chim Acta. 1980;104:329-335.
12. Kristal AR, Stanford JL, Cohen JH, Wicklund K, Patterson RE. Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:887-892.
13. Key TJ, Silcocks PB, Davey GK, Appleby PN, Bishop DT. A case-control study of diet and prostate cancer. Br J Cancer. 1997;76:678-687.
14. Platz EA, Helzlsouer KJ, Hoffman SC, Morris JS, Baskett CK, Comstock GW. Prediagnostic toenail cadmium and zinc and subsequent prostate cancer risk. Prostate. 2002;52:288-296.
15. Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL. Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst. 2003;95:1004-1007.
16. Chandra RK. Excessive intake of zinc impairs immune responses. JAMA 1984;252:1443-1446.
17. Holmes MD, Pollak MN, Hankinson SE. Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev. 2002;11:862-867.
18. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc forage-related macular degeneration and vision loss: AREDS report No. 8. Arch Ophthalmol. 2001;119:1417-1436.